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One of the purposes of antiretroviral therapy (ART) is to restore the immune system. However, it can sometimes lead to an
aberrant inflammatory response and paradoxical clinical worsening known as the immune reconstitution inflammatory syndrome
(IRIS). We describe a 23-year-old male, HIV1 infected with a rapid progression phenotype, who started ART with TCD4+ of
53 cells/mm3 (3,3%) and HIV RNA = 890000 copies/mL (6 log). Four weeks later he was admitted to the intensive care unit with
severe sepsis. The diagnostic pathway identified progressive multifocal leukoencephalopathy, digestive Kaposi sarcoma, and P.
aeruginosa bacteraemia. Five weeks after starting ART, TCD4+ cell count was 259 cells/mm3 (15%) andHIVRNA= 3500 copies/mL
(4 log). He developed respiratory failure and progressed to septic shock and death. Those complications might justify the outcome
but its autopsy opened Pandora’s box: cerebral and cardiac toxoplasmosis was identified, as well as hemophagocytic syndrome,
systemic candidiasis, andMycobacterium avium complex infection. IRIS remains a concern and eventually a barrier to ART. Male
gender, young age, low TCD4 cell count, and high viral load are risk factors. The high prevalence of subclinical opportunistic
diseases highlights the need for new strategies to reduce IRIS incidence.
1. Background
Antiretroviral therapy (ART) led to a dramatic change in
the clinical picture and prognosis of the Human Immun-
odeficiency Virus (HIV) infection. However, some patients
develop a paradoxical worsening of their clinical status
after starting therapy. HIV-associated immune reconstitution
inflammatory syndrome (IRIS) has emerged as an important
early complication of ART introduction, particularly in
patients with severe immunosuppression. The diagnosis is
based on an unexpected clinical worsening, days to months
after the ART introduction, an abrupt rise of TCD4+ cell
count, and a decrease >1 log inHIVRNA load in the presence
of pathological antigens [1]. Mortality rate is around 5.4%
[2] reaching up to 45% if concomitant opportunistic diseases
occur. Early diagnosis and therapy are crucial to a favorable
outcome but diagnosis of the leading opportunistic antigen
can be challenging.
2. Case Presentation
A 23-year-old male was diagnosed with HIV infection in
July 2011, having a negative HIV serology 6 months earlier.
By September 2011, his TCD4+ cell count was 563 cells/mm3
(15%) with a HIV RNA of 88500 copies/mL. HBV, HCV,
syphilis, Mycobacterium tuberculosis, CMV, and Toxoplasma
screenings were negative and chest X-ray, abdominal ultra-
sound, and colonoscopy were unremarkable. During the
follow-up, although presenting with a stable TCD4+ cell
count, he kept high viral load and a serodiscordant sexual
partner, those being reasons for initiating ART, which he
refused. In February 2012 secondary syphilis was diagnosed
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with a TCD4+ count of 264 cells/mm3 (7,5%) and a HIV
RNA load of 339000 copies/mL (5,5 log). Three months
later, with 53 TCD4+ cells/mm3 (3.3%) and a viral load of
890000 copies/mm3 (6 log) he was started on TDF + FTC +
EFV.
Four weeks later he was admitted to the emergency
department with fever, oral candidiasis, diarrhea, hypoten-
sion, and pancytopenia. Gastrointestinal sepsis was suspected
and he was started on ciprofloxacin and fluconazole. He
developed shock and respiratory failure in the next 48 h and
was admitted to the intensive care unit. Antibiotic regimen
was changed to imipenem, metronidazole, and fluconazole.
Faeces microbiological and parasitological tests were nega-
tive, blood and urine cultures were sterile, and CMV plasma
antigen was negative. Five weeks after starting ART there
was an increase in TCD4+ cell count [259 cells/mm3 (15%)]
and a 2 log drop in the HIV viral load [3500 copies/mm3
(4 log)]. Initial thoracic, abdominal, and pelvic CT scan
were unremarkable. Bronchial aspirate and bronchoalveo-
lar lavage (BAL) were sterile for fungi and fast growing
bacteria. PCR assays to identify Chlamydophila, Legionella,
Mycoplasma, CMV, HSV, and Mycobacterium tuberculosis
were negative. The patient remained febrile, and due to
severe pancytopenia, hepatosplenomegaly, and an elevated
ferritin, hemophagocytic syndrome was suspected, not being
confirmed on the bone marrow aspirate though. By the
9th hospitalization day he presented with seizures and the
MRI scan showed bilateral and multifocal white matter with
high signal intensity on T2-weighted and FLAIR images.
This, associated with the presence of JC virus in CSF, led to
the diagnosis of progressive multifocal leukoencephalopathy
(PML). Diarrhea persisted but due to clinical instability and
severe anemia and thrombocytopenia, endoscopic studies
were only performed on the 24th hospitalization day. Upper
and lower endoscopy revealed multiple polypoid lesions
with a cherry-red appearance in the stomach and colon,
compatible with Kaposi sarcoma (Figure 1(a)). Hewas started
on doxorubicin. Three days later, along with Pseudomonas
aeruginosa bacteraemia, the clinical state deteriorated and the
patient died.
The clinical course and the documented complications,
some of them defining AIDS, would be sufficient to explain
the poor outcome but the autopsy opened an unexpected
underworld: Kaposi sarcoma was confirmed in the stom-
ach and colon but also in the esophagus and mediasti-
nal lymph nodes (Figure 1(b)); Candida species was found
in the anal canal, colon (Figure 1(c)), and lung, where
hyaline membranes compatible with an acute respiratory
distress syndrome were also seen (Figure 1(d)). As pre-
viously suspected, prominent phagocytosis of blood cells
in the bone marrow confirmed hemophagocytic syndrome
(Figure 1(e)); brain histology showed enlarged oligoden-
droglial cells nucleus with ground glass inclusions consistent
with PML (Figure 1(f)); multiple basophilic dot-like parasites
in cysts were documented in cerebral (Figure 1(g)) and heart
tissues (Figure 1(h)) configuring cerebral andmyocardial tox-
oplasmosis. Mycobacterium avium complex culture from the
bronchial aspirate became positive after death. A. baumannii
grew from the right atrium blood culture and aspects of anal
condyloma and intraepithelial low-grade neoplasm were also
identified, as well as several aspects consistent with systemic
shock.
3. Discussion/Conclusion
Chronic HIV infection is a disease of coinfections with
immunosuppression allowing reactivation of dormant
pathogens or increasing susceptibility to exogenous ones.
The vast majority of HIV-infected patients have one or more
coinfections at some point during the disease course, which
play an important role in chronic immune activation. The
higher the antigen burden, the higher the risk for IRIS.
This case presents multiple unmasking-IRIS with systemic
Kaposi sarcoma, systemic candidiasis, and PML, coupled
with several more or less quiescent defining AIDS diseases.
Ameta-analysis with 13103 HIV-infected patients showed
that IRIS occurred in 16.1% of the cases after starting ART
[2]. This number can significantly increase in the presence
of coinfections, reaching 45%. Male gender, young age, low
TCD4+ cell count, and high viral load are all IRIS risk factors.
It has been showed that low TCD4+ cell count and high
plasmaHIVRNA levels at the time of diagnosis are associated
with a faster progression to AIDS [3]. At least 1 value of
CD4+ <100 cells/mm3 in the first year of seroconversion
seems to identify a rare group of individuals at high risk
for faster disease progression [4]. The patient in this report
had a decrease of almost 80% in TCD4+ cell count in 3
months. This subset of patients has the ability to collect
several opportunistic infections (OI) in few months, before
the risk for specific OI be identified and effective prophylaxis
started.
Several factors are independently associated with occur-
rence of OI such as African American/Black race or His-
panic/Latino ethnicity, intravenous drug users, heterosexual
HIV transmission, lower TCD4+ cell count, and higher viral
load [5]. Sixteen large cohorts of HIV-infected patients were
recently evaluated and reported a decrease in the incidence
rates of first OIs, from 2.96 events/100 person-years in
2000–2003 to 1.45 events/100 person-years in 2008–2010 [5].
The improvements in viral suppression and immune status
associated with newer ART regimens played a major role
in the picture of OI. Levels of TCD4+ cell count below
which specificOIs tend to occur were never absolute. Patients
that started ART during 2008–2010 had a 7% probability
of developing a new OI within 2 years when the initial
TCD4+ cell count was <200 cell/mm3 but only 1% when the
initial TCD4+ cell count was≥500 cells/mm3 [5].Themedian
TCD4+ cell count is usually above or close to 200 cells/mm3
for tuberculosis and isosporiasis infections and less than
100 cells/mm3 for candidiasis, PCP, CMV infection, and
MAC infection [5]. On the other hand, OIs also have an
impact on TCD4+ cell count as the latter decrease at a rate
of 24.1 cells/mL per three months in the presence of OI,
compared to an increase of 21.3 cells/mL per three months
in its absence [6]. In this report, the patient had a rapid
decline in TCD4+ cells to 53 cells/mm3 leading to a profound
immunosuppressed state, which dramatically increased the
risk for several OI in a short period of time.
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Figure 1: (a) Gastric Kaposi sarcoma: scarlet slightly elevated lesions of the antral gastric mucosal surface (upper gastrointestinal endoscopy).
(b) Mediastinal ganglia Kaposi sarcoma: submucosal vascular spindle-shaped cells (H&E-stain, 100x). (c) Candida spp. in colon (Grocott
methenamine silver-stain, 100x). (d) Candida spp. in lung and hyaline membranes suggesting acute respiratory distress syndrome (H&E-
stain, 100x). (e) Bonemarrow hemophagocytosis (H&E-stain, 400x). (f) Progressivemultifocal leukoencephalopathy: enlarged homogeneous
oligodendrocyte nucleus with inclusion (H&E-stain, 100x). (g) Cerebral toxoplasmosis: Toxoplasma cyst (H&E-stain, 100x). (h) Cardiac
toxoplasmosis: Toxoplasma cyst (H&E-stain, 100x).
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Along with depression of immune system, OI pre-
sentation becomes blurred and the diagnosis is difficult.
Our patient, despite his profound immunosuppression, was
asymptomatic until the start of ART. KS is the most com-
monHIV-associatedmalignancy and disease exacerbation or
presentation after starting ART can be as high as 29% [7].
Central nervous system IRIS contributes to the bulk of IRIS
mortality: JC virus infection is the third cause afterMycobac-
terium tuberculosis and Cryptococcus neoformans; cerebral
toxoplasmosis is rare. Twelve to 22% of AIDS patients had
endomyocardial involvement by T. gondii at autopsy; in the
highly activeART era the prevalence of cardiac toxoplasmosis
confirmed postmortem has been reported to be less than 10%
[8]. The incidence of M. avium complex infection related to
IRIS, in the presence of TCD4+ <100 cells/mm3, is 3.5% [9].
Early HIV infection detection and treatment are crucial
to a better prognosis. Recent changes in the treatment
guidelines are expected to reduce IRIS incidence, particularly
by reducing the duration and degree of immunosuppression.
Nevertheless, systematic screening forOI before startingART
is still a key element to prevent this phenomenon. The risk
of paradoxical IRIS could also be substantially altered by
deferral of ART initiation, particularly in central nervous
system IRIS. This approach is postulated to ensure adequate
treatment of OI, reduce the antigen burden before starting
ART inHIV-infected patientswith severe immunedeficiency,
and promote immune recovery.
Despite the lack of standardized treatment protocol for
IRIS, ART should not be interrupted and there may be a
need for corticosteroid therapy. As such, treatment of these
patients is a huge challenge and further research regarding the
immunopathogenesis, diagnosis, and its management should
be pursued.
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